Biohaven Ltd.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−6.49%
vs ±14.7% implied · ×0.44
shaded = implied · ▲▼ = realized
Biohaven Ltd.
15.44
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $196.6M | 9.16% | +17.72% | |
| 2 | Suvretta Capital ManagementSuvretta | $153.1M | 7.13% | 0.00% | |
| 3 | Stifel FinancialStifel Financial | $147.9M | 6.89% | 0.00% | |
| 4 | Jupiter TopcoJupiter Topco | $127.9M | 5.96% | — | |
| 5 | Woodline PartnersWoodline Partners | $114.0M | 5.31% | +2450.12% | |
| 6 | State StreetState Streetindex-like | $103.4M | 4.82% | +4.96% | |
| 7 | Infinitum Asset ManagementInfinitum | $93.0M | 4.33% | 0.00% | |
| 8 | D. E. ShawD. E. Shaw | $62.4M | 2.91% | +47.17% | |
| 9 | AQR Capital ManagementAQR | $61.8M | 2.88% | +110.10% | |
| 10 | Geode Capital ManagementGeodeindex-like | $49.5M | 2.30% | +20.07% | |
| 11 | FMRFMR | $44.1M | 2.06% | +25.67% | |
| 12 | Royalty Pharma Sub-ManagerRoyalty Pharma Sub-Manager | $43.7M | 2.04% | 0.00% | |
| 13 | Cormorant Asset ManagementCormorant | $38.8M | 1.81% | +48.30% | |
| 14 | Goldman Sachs GroupGoldman Sachs | $38.4M | 1.79% | +2.78% | |
| 15 | UBS GroupUBS | $37.5M | 1.75% | +76.58% | |
| 16 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $37.0M | 1.73% | +9.20% | |
| 17 | Citadel AdvisorsCitadel | $30.4M | 1.42% | +4.55% | |
| 18 | Balyasny Asset ManagementBalyasny | $28.0M | 1.30% | −23.13% | |
| 19 | TCG Crossover ManagementTCG Crossover | $26.5M | 1.23% | −61.57% | |
| 20 | NuveenNuveenindex-like | $26.0M | 1.21% | +133.90% | |
| 21 | Rubric Capital ManagementRubric | $25.6M | 1.19% | new | |
| 22 | StemPoint CapitalStemPoint Capital | $23.3M | 1.08% | −1.90% | |
| 23 | Vanguard Capital ManagementVanguardindex-like | $22.2M | 1.03% | +17.24% | |
| 24 | Bank of AmericaBank of America | $22.0M | 1.02% | +94.60% | |
| 25 | T. Rowe Price AssociatesT. Rowe Price | $21.7M | 1.01% | −34.29% |
296 managers report $2.1B of Biohaven on form 13F for the quarter ended Jun 30 '26. 34 of them hold 80% of it; BlackRock is largest at 9.16%.
Linked news
Expected move
Inputsspot 15.42exp Mar 19ATM strike 15ATM straddle 7.50IV 102%